Ondine Biomedical Inc. (OBI.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In GBp
| Market Cap | 75.12M |
| Enterprise Value | 64.95M |
| P/E Ratio | -2.99 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 37.88 |
| Price/Book Ratio | -31.81 |
| Enterprise/Revenue | 36.1 |
| Enterprise/EBITDA | -3.17 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -11.5 |
| Operating Margin | -11.59 |
| Return On Assets | -3.67 |
| Return On Equity | -247.32 |
| Revenue | 2.65M |
| Revenue/Share | 0.01 |
| Gross Profit | 1.09M |
| EBITDA | -29.45M |
| Net Income | -29.59M |
| Diluted EPS | -0.06 |
| Total Cash | 5.36M |
| Total Cash/Share | 0.01 |
| Total Debt | 278,874 |
| Total Debt/Equity | -0.09 |
| Current Ratio | 0.65 |
| Book Value Per Share | -0.01 |
| 52-Week Change | -18 |
| 52-Week High | 15.5 |
| 52-Week Low | 0.1 |
| Moving Average 50 Days | 9.57 |
| Moving Average 200 Days | 11.45 |
| Average Volume | 488,887 |
| Shares Outstanding | 561.22M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |